A Comparative Pharmacokinetics Study of the Anti-Parkinsonian Drug Pramipexole

The present study aimed to compare pharmacokinetic parameters of two pramipexole 0.25 mg formulations in order to show bioequivalence. The study was conducted in a randomized, open-label, two-period, two-sequence, and crossover design, involving 23 healthy volunteers. One of the 0.25 mg formulations...

Descripción completa

Detalles Bibliográficos
Autores principales: Putri, Ratih S. I., Setiawati, Effi, Aziswan, Syifa A., Ong, Fenny, Tjandrawinata, Raymond R., Susanto, Liana W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198030/
https://www.ncbi.nlm.nih.gov/pubmed/27869754
http://dx.doi.org/10.3390/scipharm84040715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198030/
https://www.ncbi.nlm.nih.gov/pubmed/27869754
http://dx.doi.org/10.3390/scipharm84040715

Ejemplares similares